Evidence-based cancer care is a scientific discussion.

In the conventional cancer world, the Food and Drug Administration (FDA) testing procedure generally known as – “the gold standard” – prevails as the barometer to prove the safety and effectiveness of drugs, treatments, and therapies. In brief, this standard revolves around: large, randomized, placebo-based, double-blind, evidence-based research studies. They often take 10-15 years to complete, from start to finish. They assess and evaluate drugs and therapies beginning with the evaluation of cancer cell lines, then proceeding to preclinical studies (animal studies, frequently mice). Animal studies are followed by phase 1 trials consisting of small groups of people (approximately, 20 to 80), then phase 2 (approximately, several dozens to 300), followed by phase 3 trials which are comprised of even larger groups of people (approximately several hundred to 3,000). Each succeeding phase continues, subject to safe and effective results being demonstrated in the preceding phase.